NCT03618797View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia

PHASE3CompletedINTERVENTIONAL

Enrollment

347

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

May 31, 2018

Conditions

Complex-dyslipidemia

Interventions

DRUG

HL-PIF cap.160/2mg + Placebo

Fenofibrate pellet (as micronized fenofibrate 160mg) and Pitavastatin Ca 2mg

DRUG

Livalo tab. 2mg + Placebo

Pitavastatin ca 2mg

All Listed Sponsors

lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT03618797 - A Clinical Trial to Evaluate the Efficacy and Safety of Pitavastatin/Fenofibrate in Complex-dyslipidemia | Biotech Hunter | Biotech Hunter